SCHEMBL288947

SCHEMBL288947

C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](OC(=O)CC[C@@H](C)[C@H]5CCC6C7CCC8CCCC[C@]8(C)C7CC[C@@]65C)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 5/20 0.63
LMNA P02545 2/20 0.63
MEN1 O00255 2/20 0.63
KMT2A Q03164 2/20 0.63
AKR1B10 O60218 1/20 0.63
AKR1B1 P15121 1/20 0.63
EFNA1 P20827 1/20 0.63
EPHA2 P29317 1/20 0.63
PSEN1 P49768 1/20 0.63
PSEN2 P49810 1/20 0.63
APH1B Q8WW43 1/20 0.63
NCSTN Q92542 1/20 0.63
APH1A Q96BI3 1/20 0.63
PSENEN Q9NZ42 1/20 0.63
HSD17B10 Q99714 1/20 0.63
TDP1 Q9NUW8 1/20 0.63
NR1H4 Q96RI1 3/20 0.62
CYP3A4 P08684 3/20 0.62
PDE3A Q14432 1/20 0.62
USP2 O75604 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23231215 0.93 GPBAR1 (0.72) GPBAR1LMNAMEN1KMT2AAKR1B10
SCHEMBL288122 0.93 GPBAR1 (0.72) GPBAR1LMNAMEN1KMT2AAKR1B10
SCHEMBL288704 0.93 GPBAR1 (0.72) GPBAR1LMNAMEN1KMT2AAKR1B10
SCHEMBL2467588 0.92 GPBAR1 (0.72) GPBAR1LMNAMEN1KMT2AAKR1B10
SCHEMBL7532429 0.92 GPBAR1 (0.68) GPBAR1LMNAMEN1KMT2AAKR1B10
Cholic Acid SCHEMBL437269 0.90 GPBAR1 (0.71) GPBAR1LMNAMEN1KMT2AAKR1B10
Cholic Acid SCHEMBL288946 0.90 GPBAR1 (0.78) GPBAR1LMNAMEN1KMT2AAKR1B10
Cholic Acid SCHEMBL437268 0.90 GPBAR1 (0.78) GPBAR1LMNAMEN1KMT2AAKR1B10
SCHEMBL1758946 0.88 GPBAR1 (0.67) GPBAR1LMNAMEN1KMT2ATDP1
SCHEMBL1287858 0.88 GPBAR1 (0.78) GPBAR1LMNAMEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2449488-A1 METHOD FOR NORMALIZATION IN METABOLOMICS ANALYSIS METHODS WITH ENDOGENOUS REFERENCE METABOLITES BIOCRATES Life Sciences AG (AT) 2012-05-09 EP disclosed
EP-2427773-A1 METHOD OF DIAGNOSING ASPHYXIA Keller, Matthias (DE) 2012-03-14 EP disclosed
WO-2011000753-A1 METHOD FOR NORMALIZATION IN METABOLOMICS ANALYSIS METHODS WITH ENDOGENOUS REFERENCE METABOLITES BIOCRATES LIFE SCIENCES AG (AT) 2011-01-06 WO disclosed
WO-2010128054-A1 METHOD OF DIAGNOSING ASPHYXIA BIOCRATES LIFE SCIENCES AG (AT) 2010-11-11 WO disclosed
WO-1996038464-A1 ANTIMICROBIAL STEROL CONJUGATES LEHIGH UNIVERSITY (US) 1996-12-05 WO disclosed